Agenus Inc (AGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4419FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Agenus Inc (AGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company that discovers, develops and commercializes a wide range of immunotherapeutics for the treatment of various types of cancers and infectious diseases. The company’s pipeline portfolio encompasses vaccines for glioblastoma, genital herpes and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The company’s technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. The company has collaborations with several pharmaceutical companies such as GSK, Incyte, and Merck. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Agenus Inc Key Recent Developments

Mar 15,2021: Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Mar 02,2021: Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Feb 09,2021: Andy Hurley named Agenus Chief Commercial Officer
Jan 19,2021: Agenus to Participate in B. Riley Securities’ Oncology Investor Conference
Nov 09,2020: Agenus presents additional clinical responses and novel biomarker data at SITC2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Agenus Inc – Key Facts
Agenus Inc – Key Employees
Agenus Inc – Key Employee Biographies
Agenus Inc – Major Products and Services
Agenus Inc – History
Agenus Inc – Company Statement
Agenus Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Agenus Inc – Business Description
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
Agenus Inc – Corporate Strategy
Agenus Inc – SWOT Analysis
SWOT Analysis – Overview
Agenus Inc – Strengths
Agenus Inc – Weaknesses
Agenus Inc – Opportunities
Agenus Inc – Threats
Agenus Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Agenus Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2021: Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Mar 02, 2021: Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Feb 09, 2021: Andy Hurley named Agenus Chief Commercial Officer
Jan 19, 2021: Agenus to Participate in B. Riley Securities’ Oncology Investor Conference
Nov 09, 2020: Agenus presents additional clinical responses and novel biomarker data at SITC2020
Nov 05, 2020: Dr. Steven O’Day named Agenus Chief Medical Officer
Oct 29, 2020: Agenus R&D update & third quarter financial report
Oct 14, 2020: Agenus to present on seven novel programs at SITC 2020
Oct 13, 2020: Susan Hirsch joins Agenus board of directors
Aug 31, 2020: Paul Clark joins Agenus board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Agenus Inc, Key Facts
Agenus Inc, Key Employees
Agenus Inc, Key Employee Biographies
Agenus Inc, Major Products and Services
Agenus Inc, History
Agenus Inc, Subsidiaries
Agenus Inc, Key Competitors
Agenus Inc, Ratios based on current share price
Agenus Inc, Annual Ratios
Agenus Inc, Annual Ratios (Cont...1)
Agenus Inc, Interim Ratios
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Agenus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Agenus Inc (AGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析
    Summary Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company's pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding pro …
  • High-Tech Grunderfonds Management GmbH:企業のM&A・事業提携・投資動向
    High-Tech Grunderfonds Management GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's High-Tech Grunderfonds Management GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Luzhou Bio-chem Technology Limited:企業の戦略・SWOT・財務分析
    Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report Summary Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Eng Kah Corporation Berhad:企業の戦略・SWOT・財務情報
    Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mirvac Group:企業の戦略・SWOT・財務情報
    Mirvac Group - Strategy, SWOT and Corporate Finance Report Summary Mirvac Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CIRFOOD Cooperativa Italiana di Ristorazione s.c.:企業の戦略・SWOT・財務情報
    CIRFOOD Cooperativa Italiana di Ristorazione s.c. - Strategy, SWOT and Corporate Finance Report Summary CIRFOOD Cooperativa Italiana di Ristorazione s.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TFS Financial Corp:企業の戦略・SWOT・財務分析
    TFS Financial Corp - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lanxess AG:企業の戦略・SWOT・財務情報
    Lanxess AG - Strategy, SWOT and Corporate Finance Report Summary Lanxess AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Levi Strauss & Co (LEVI):企業の財務・戦略的SWOT分析
    Levi Strauss & Co (LEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Southwire Company, LLC:企業の戦略・SWOT・財務情報
    Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report Summary Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ping An Insurance (Group) Company of China Ltd (601318):企業の財務・戦略的SWOT分析
    Ping An Insurance (Group) Company of China Ltd (601318) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • The British Land Company PLC:企業の戦略・SWOT・財務分析
    The British Land Company PLC - Strategy, SWOT and Corporate Finance Report Summary The British Land Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SYSTRA S.A.:企業の戦略・SWOT・財務情報
    SYSTRA S.A. - Strategy, SWOT and Corporate Finance Report Summary SYSTRA S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Pyxant Labs Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that provides good laboratory practice (GLP) bioanalytical chemistry support and contract research services. The laboratory offers services such as picogram-level bioanalytical method development, analytical and bioanalytical support for …
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務情報
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Technical Olympic SA:企業の戦略・SWOT・財務情報
    Technical Olympic SA - Strategy, SWOT and Corporate Finance Report Summary Technical Olympic SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Consolidated Edison Inc (ED):石油・ガス:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆